Vital Therapies reported $99.3M in Market Capitalization this September of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Biomarin Pharmaceutical BMRN:US $ 15.33B 1.08B
Dynavax Technologies DVAX:US $ 1.59B 0.24B
Enanta Pharmaceuticals ENTA:US $ 0.98B 0.48B
Epizyme EPZM:US $ 0.25B 0.06B
Insmed INSM:US $ 2.36B 0.43B
Intercept Pharmaceuticals ICPT:US $ 0.41B 0.07B
Mirati Therapeutics MRTX:US $ 3.73B 0.84B
Omeros OMER:US $ 0.17B 0.2B
Orasure Technologies OSUR:US $ 0.2B 0.3B
Quidel QDEL:US $ 6.5B 1.8B
Regulus Therapeutics RGLS:US $ 0.03B 0.01B
Revance Therapeutics RVNC:US $ 1.01B 0.39B
Ultragenyx Pharmaceutical RARE:US $ 4.17B 0.87B
United Therapeutics UTHR:US $ 10.67B 2.55B
Vital Therapies VTL:US $ 0.08B 0.25B
Xoma XOMA:US $ 0.26B 0.06B